Do You Know The Supply And Demand Of Protective Clothing And Respirators? The Latest Situation Of Anti Epidemic Medical Supplies Is Here.

The joint defense joint control mechanism of the State Council held a news conference on April 8th afternoon to introduce the production and support work of medical materials.

- epidemic situation -

Insisting on the combination of emergency disposal and normal prevention and control

In April 7th, the number of locally confirmed cases fell. The following 500 cases The number of close contacts who are still under medical observation. For 7 consecutive days 。 The proportion of overseas confirmed cases and asymptomatic infections increased continuously, and the related cases were sporadic. Along with the lifting of the Han Dynasty passage control and the increase of personnel flow in Wuhan, we must adhere to the combination of emergency disposal and normalization prevention and control, and do a good job in epidemic prevention and control for key links and risk points.

Domestic material supply --

Protective clothing, respirators and other protective materials capacity basically meet domestic demand.

As of April 5th, disposable medical protective clothing can reach more than 1 million 500 thousand daily output. The medical N95 mask has over 3 million 400 thousand capacity per day. The company will focus on tracking the daily medical isolation Eyewear / mask of Nissan to 290 thousand, the automatic infrared thermometer's daily capacity of 10 thousand units, and the hand-held infrared thermometer's daily capacity of 400 thousand units. The main production enterprises have supplied more than 2.9 kinds of ventilators to the whole country, of which nearly 18 thousand units are supplied to Hubei, including 3000 sets of breathing machines. From the perspective of supply and demand, medical protective clothing, medical respirator, medical isolation eye mask / mask, thermometer and ventilator capacity have basically met domestic demand. Enterprises are also trying to organize export expansion.

The supply of drugs is stable and sufficient to achieve "medicine and others".

After the relevant drugs are included in the "diagnosis and treatment plan", ensure stable and adequate supply and achieve "medicine and others". Up to now, Chloroquine phosphate Nissan can reach 100 thousand people and produce 670 thousand people. Al al al Nissan can produce 50 thousand people and produce 800 thousand people. De France Nissan can produce 11 thousand and 500 people, and it has produced 137 thousand and 500 people. The 14 kinds of proprietary Chinese medicines included in the diagnosis and treatment plan are relatively adequate and the market supply is guaranteed. Up to now, Lianhua Qingwen capsule Nissan can reach 2 million boxes and stock 30 million boxes. Golden Flower and clear feeling Nissan can reach 26 thousand boxes and stock 400 thousand boxes.

Foreign material supply --

More than 100 countries put forward demand for materials.

As of the end of March, a total of more than 100 countries and international organizations have submitted relevant materials demand to China. It covers protective clothing, respirators, goggles, thermometers, ventilators and medicines. etc. 。 The State Council has established a corresponding working mechanism, and the Ministry of industry and Commerce will cooperate with the Ministry of foreign affairs and the Ministry of Commerce and other relevant departments to organize and implement the production and supply of related materials. In addition, the group has signed 360 million contracts with 88 countries and international organizations, and has shipped more than 100 million pieces to 64 countries.

There are nearly 18 thousand ventilators abroad, but it is not realistic to meet global needs.

At present, the ventilator supplied to foreign countries is near. 18 thousand stations Among them, there are more than 4000 invasive ventilators. The production of ventilators is restricted by the supply of the core parts of the globalization. China's capacity is less than that of the global 1/5. Even if the supply of key parts is guaranteed, it is not realistic to fully meet the needs of the global epidemic prevention and control.

Global protection of protective clothing is subject to differences in quality standards and usage habits between China and foreign countries.

The average daily output of protective clothing in China has exceeded 1 million 500 thousand sets. In theory, the problem of meeting the needs of the international market is not too big. But these protective clothing are According to different quality standard systems in China, the United States, the European Union and Japan Production does not match the requirements of importing countries and regions. Recently, the Ministry of Commerce, the General Administration of customs and the State Administration of Drug Administration issued regulations that 5 types of products, such as test reagents for export, are required to be qualified for the domestic pharmaceutical production sector and to meet the quality standards of the importing countries and regions.

- production capacity -

Full recovery of API production

China is the world's largest producer of chemical raw material drugs. On the whole, the output of API in the first quarter of this year was basically the same as that of last year, and the production of API has been fully restored. Affected by recent difficulties in logistics and transportation, the actual export volume of API has been reduced by about 20% compared with last year. but API, which is related to the treatment of new crown pneumonia, has achieved adverse market growth. 。 For example, vitamin C, China's annual output of about 150 thousand tons, accounting for more than 90% of the world's output. Output in the first quarter of this year was basically the same as last year, and exports increased by 10% over the same period last year. For example, paracetamol, an antipyretic analgesic, has an annual output of nearly 80 thousand tons, accounting for more than 60% of the world's output. Output in the first quarter of this year increased by 20% and exports increased by 30%. The annual output of hydroxychloroquine sulfate is 100 tons, and the export volume in the first quarter of this year has exceeded the level of last year.

There are short boards for high-end medical equipment.

China's medical equipment manufacturing enterprises have provided more than 11.5 medical equipment to the whole country, of which more than 38 kinds of equipment have been provided to Hubei, and more than 7 sets of equipment have been provided. Most of the medical devices such as central electric monitor, hemodialysis machine and blood gas analyzer meet the needs of epidemic prevention and control and patient rescue, and have laid the foundation for winning the prevention and control of the epidemic. However, in the process, it also highlights the shortcomings and weaknesses of the development of the industry. For example, ECMO and other high-end medical equipment, domestic enterprises can not produce. The supply of invasive ventilator is not enough, some products need to be improved, and the standard system is not perfect. At present, experts in medical and health care, medical equipment and other fields are being organized to comb out the weaknesses of medical equipment, and take effective measures to break through the bottleneck of key core technologies, components and equipment. Speed up the short board of our high-end medical equipment.